Health Condition 1: C800- Disseminated malignant neoplasm, unspecified
Conditions
Interventions
Intervention1: Intravenous Iron Therapy (Ferrous Carboxymaltose): Dose : Calculated By Modified Ganzoni Formula ,Upto 1000 mg Ferrous carboxymaltose.
Frequency :One Single dose.
Route of administrat
Sponsors
AIIMS New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients of age group 18 and 80 years of either sex. 2) Performance status of 0â??3 on the (ECOG performance status) scale. 3) Metastatic non myeloid cancer patient not on any curative /palliative chemotherapy or radiation therapy. 4) Hemoglobin ranging from 8gm/dl to 12 gm/dl in women and 8gm/dl to 13 gm/dl in Men (as per WHO Definition).
Exclusion criteria
Exclusion criteria: 1) Age below 18 years. 2) Patients with blood transfusion in the last one month. 3) Patients receiving active therapy or had completed chemotherapy/radiation one month back. 4) Presence of dementia, agitation, or delirium or mental disorder. 5) Terminally ill patients with PS greater than 3. 6) Hemoglobin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the Role of IV iron therapy on fatigue and quality of life in patients of palliative care. Timepoint: Baseline ,1 week ,1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Assessing the Symptom burden of Fatigue in palliative care. 2.Prevalence of fatigue in patients on palliative care. Timepoint: At baseline | — |
Countries
India
Contacts
Public ContactAnurag sarkar
AIIMS New Delhi
Outcome results
None listed